Evaluation of Low Source of Signal in SCOUT DS

NCT01339637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 196

Last updated 2012-12-05

No results posted yet for this study

Summary

The overall objective of this study is to increase the number of dark skin tone individuals in the data set and evaluate if this increase in dark skin tone data has an impact on the accuracy of the SCOUT DS Diabetes Risk Score (DRS).

Conditions

  • Metabolic Syndrome
  • Impaired Glucose Tolerance
  • Gestational Diabetes

Sponsors & Collaborators

  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • John Maynard, MS · VeraLight, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-09-30
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01339637 on ClinicalTrials.gov